There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Immunic (IMUX – Research Report) and OncoSec Medical (ONCS – Research Report) with bullish sentiments. Immunic (IMUX) Wedbush analyst Liana Moussatos reiterated a Buy rating on Immunic today and set a price target of $61.00. The company's shares closed last Wednesday at $8.85, close to its 52-week low of $6.96. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-immunic-imux-oncosec-medical-oncs?utm_source=advfn.com&utm_medium=referral
OncoSec Medical (NASDAQ:ONCS)
Historical Stock Chart
From Apr 2022 to May 2022 Click Here for more OncoSec Medical Charts.
OncoSec Medical (NASDAQ:ONCS)
Historical Stock Chart
From May 2021 to May 2022 Click Here for more OncoSec Medical Charts.